201 related articles for article (PubMed ID: 17969399)
1. [Survival of patients with ovarian cancer in the Ul'ianovsk Region, 1999-2005].
Antoneeva II
Vopr Onkol; 2007; 53(4):393-5. PubMed ID: 17969399
[No Abstract] [Full Text] [Related]
2. Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.
Lenhard M; Lennerová T; Ditsch N; Kahlert S; Friese K; Mayr D; Jeschke U
Histopathology; 2011 May; 58(6):990-4. PubMed ID: 21585434
[No Abstract] [Full Text] [Related]
3. [Clinico-prognostic factors in cancer of the ovaries].
Ali-Zade VA; Atakishiev AR
Vopr Onkol; 1990; 36(8):1005-6. PubMed ID: 2171225
[No Abstract] [Full Text] [Related]
4. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
5. [Pathology of ovarian cancer].
Kaku T; Ogawa S; Hirakawa T; Ohishi Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():471-5. PubMed ID: 15535290
[No Abstract] [Full Text] [Related]
6. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
Hefler LA; Grimm C; Ackermann S; Malur S; Radjabi-Rahat AR; Leodolter S; Beckmann MW; Zeillinger R; Koelbl H; Tempfer CB
Cancer Res; 2003 Jun; 63(12):3066-8. PubMed ID: 12810629
[TBL] [Abstract][Full Text] [Related]
7. Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.
Köbel M; Kalloger SE; Santos JL; Huntsman DG; Gilks CB; Swenerton KD
Gynecol Oncol; 2010 Jan; 116(1):50-6. PubMed ID: 19822358
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666
[TBL] [Abstract][Full Text] [Related]
10. [Pathology of ovarian cancer].
Kaku T; Watanabe S; Ohishi Y
Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
[No Abstract] [Full Text] [Related]
11. [Age-related features of observed and relative survival among ovarian cancer patients in St. Petersburg, Russia].
Merabishvili VM; Bogdanova EM; Urmancheeva AF; Diatchenko OT; Chepik OF; Safronnikova NR; Laliantsi EL
Vopr Onkol; 2010; 56(3):283-92. PubMed ID: 20804049
[No Abstract] [Full Text] [Related]
12. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
[TBL] [Abstract][Full Text] [Related]
14. [The degree of differentiation and the clinical course of ovarian cancer].
Vinokurov VL; Iurkova LE; Zagol'skaia VN
Vopr Onkol; 1985; 31(3):55-63. PubMed ID: 2986351
[TBL] [Abstract][Full Text] [Related]
15. Biologic behavior of primary ovarian malignancy.
Julian CG; Goss J; Blanchard K; Woodruff JD
Obstet Gynecol; 1974 Dec; 44(6):873-84. PubMed ID: 4373686
[No Abstract] [Full Text] [Related]
16. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
17. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
[TBL] [Abstract][Full Text] [Related]
19. Epithelial ovarian carcinoma of low malignant potential.
Barnhill D; Heller P; Brzozowski P; Advani H; Gallup D; Park R
Obstet Gynecol; 1985 Jan; 65(1):53-9. PubMed ID: 2981419
[TBL] [Abstract][Full Text] [Related]
20. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
